ArticleAnnals of surgical oncology2026
Single-Cell Transcriptomics Reveals Key Factors in Gastric Intestinal Metaplasia.
Article in Annals of surgical oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
backgroundGastric cancer is among the deadliest cancers worldwide, and gastric intestinal metaplasia is a key precancerous phase. Understanding the molecular drivers of abnormal proliferation in intestinal metaplasia (IM) is vital for identifying biomarkers and therapeutic targets. MATERIALS AND
methodsUsing single-cell RNA sequencing, we characterized the cellular and molecular dynamics of gastric epithelial tissues across disease stages: control, chronic superficial gastritis, and IM.
resultsWe identified nine cell types, predominantly epithelial cells, that exhibited increased proliferation with disease progression, suggesting their role in early gastric carcinogenesis. Notably, the regulatory gene TFF3 was significantly upregulated in IM-associated goblet cells (log
conclusionsThese findings suggest that TFF3 may drive the early stages of gastric cancer, although the precise regulatory mechanisms involved remain to be fully elucidated. Additionally, this research may provide valuable insights into the mechanisms underlying other precancerous lesions and related malignancies.
Indexed as
Identifiers
41492114What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.